Patient P-01856
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S13
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability-9
- Toxicity-9
- Nutritional resilience+6
- Inflammatory activity-3
- Treatment adherence+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion14.4/100
worsening · +1.7 vs previous 14 d
Toxicity
Blood14.8/100
improving · -3.4 vs previous 14 d
Sleep quality
Wearable39.3/100
stable · -0.3 vs previous 14 d
Energy level
Daily log5.8/10
stable · +0.1 vs previous 14 d
Stress level
Daily log3.6/10
stable · +0.0 vs previous 14 d
Steps
Wearable5,859
worsening · -319 vs previous 14 d
Adherence
Companion91.4 %
stable · +0.7 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 82 from the failing basin, 12 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
Main detractors to watch
- Histamine loadperturbation · steering -13.2
- FUT2 non-secretorhidden · steering -10.6
- Bacteroides fragilis elevatedhidden · steering -7.4
- Poor-sleep weekperturbation · steering -3
- Histamine loaddetractor · GI +7.2 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+7.2detractor · 95%
- Alcohol+3.1no signal · 49%
- Spicy / capsaicin+1.9no signal · 29%
- Dietary fat load+0.4no signal · 15%
- Insoluble fibre-0.4no signal · 15%
- Simple carbohydrates-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓60
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 4.1 · butyrate capacity 60/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 56 ms
- Sleep
- 6.6 h
- Steps
- 6,453
- Resting HR
- 65 bpm
Daily log: GI score 14, nutritional resilience 68, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.